Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
1 Introduction Ovarian cancer is among the most common and most deadly types of gynecologic malignancy. Most ovarian cancer patients are diagnosed at advanced stage. The treatment options are limited, mainly involving surgery, platinum-based chemotherapy and PARP inhibitor [1]. In spite of multiple therapies, most ovarian cancer patients eventually relapse with low 5-year survival rate of less than 35% [2].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.